Form 4 for ROIV Roivant Sciences Ltd.
Accepted 2026-07-02 19:03:57 ET · period of report 2026-06-30 · accession 0001349297-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-02 19:03 | 2026-06-30 | ROIV | Fitzgerald Meghan | Dir | M - OptEx | $8.80 | +10.0K | 53.0K | +23% | +$88.0K |
| DT | 2026-07-02 19:03 | 2026-06-30 | ROIV | Fitzgerald Meghan | Dir | S - Sale+OE | $34.90 | -10.0K | 43.0K | -19% | -$349.0K |
| DT | 2026-07-02 19:03 | 2026-06-30 | ROIV | Fitzgerald Meghan | Dir | M - OptEx | $0.00 | -10.0K | 38.6K | -21% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-06-30 | M | A | 10,000 | $8.80 | 52,963 | D | — | — | |
| 2 | Common | Common Shares | 2026-06-30 | S | D | 10,000 | $34.90 | 42,963 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-06-30 | M | D | 10,000 | $0.00 | 38,578 | D | $8.80 · — to 2033-04-19 | 10,000 Common Stock | (F1) Award of stock options to purchase Common Shares that is fully vested. |